1999
DOI: 10.1002/1531-8249(199912)46:6<834::aid-ana5>3.0.co;2-m
|View full text |Cite
|
Sign up to set email alerts
|

Neurocognitive deficits in medulloblastoma survivors and white matter loss

Abstract: Although previous studies have documented a significant risk of intellectual loss after treatment for childhood medulloblastoma (MED), the pathophysiology underlying this process is poorly understood. The purpose of this study was to test the hypotheses that (1) patients treated for MED in childhood have reduced volumes of normal white matter (NWM) related to their treatment with craniospinal irradiation with or without chemotherapy, and (2) deficits in NWM among patients surviving MED can at least partially e… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

9
128
0
2

Year Published

2004
2004
2022
2022

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 197 publications
(139 citation statements)
references
References 35 publications
9
128
0
2
Order By: Relevance
“…A few days following administration, some patients have developed a toxic leukoencephalopathy with altered mental status and multifocal deficits. Within days to weeks, a transverse myelopathy with pain, sensory loss, paraplegia, and bladder dysfunction can [11][12][13] Treatment with low doses of purine analogs such as fludarabine (used in Case 1), cytarabine (used in Case 3), and 5-fluorouracil (used in Case 4) has also previously been known to result in at least rare white matter changes. These effects have generally been mild and reversible.…”
Section: Discussionmentioning
confidence: 99%
“…A few days following administration, some patients have developed a toxic leukoencephalopathy with altered mental status and multifocal deficits. Within days to weeks, a transverse myelopathy with pain, sensory loss, paraplegia, and bladder dysfunction can [11][12][13] Treatment with low doses of purine analogs such as fludarabine (used in Case 1), cytarabine (used in Case 3), and 5-fluorouracil (used in Case 4) has also previously been known to result in at least rare white matter changes. These effects have generally been mild and reversible.…”
Section: Discussionmentioning
confidence: 99%
“…Long-term survivors of pediatric brain tumors suffer a variety of cognitive deficits in intelligence, memory, attention, and fine-motor functions (Copeland et al, 1985;Konczak et al, 2005;Mulhern et al, 1988;Mulhern et al, 1999;Mulhern et al, 2004;Palmer et al, 2001;Reeves et al, 2006;Steinlin et al, 2003). Cognitive deficits may be caused by brain tumors located in the central nervous system (CNS) or by treatments directed at the CNS such as chemotherapy and cranial radiation therapy (CRT).…”
Section: Introductionmentioning
confidence: 99%
“…Many studies have investigated the association between CNS-directed treatment and structural damage of the brain. Brain structural changes such as atrophy from gray and white matter loss or developmental deficits in the corpus callosum that are known to occur after CNS-directed treatments have been correlated with cognitive deficits (Macedoni-Luksic et al, 2003;Mulhern et al, 1999;Mulhern et al, 2001;Palmer et al, 2002;Reddick et al, 2003;Reddick et al, 2005;Steen et al, 2001), but the specific neural substrates of those deficits are largely unknown. Neuroimaging techniques, including functional MRI (fMRI) and diffusion tensor imaging (DTI), are promising new tools to investigate brain structure and function in such patients Phillips et al, 2005;Ries et al, 2004;Zou et al, 2005).…”
Section: Introductionmentioning
confidence: 99%
“…The decrease in the amount of normalappearing white matter also correlated with the craniospinal radiation dose (24). Decreased amounts of normalappearing white matter correlated with decreases in fullscale intelligence quotient (IQ), factual knowledge, verbal thinking, nonverbal thinking, attention, and academic achievement (22,23,25).…”
Section: Introductionmentioning
confidence: 99%